RIGL FY 2016 Earnings — Rigel Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

RIGLRigel Pharmaceuticals, Inc.

$517M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$20M-29.5% YoY

Gross Profit

-$43M-211.3% margin

Operating Income

-$70M-342.2% margin

Net Income

-$69M-339.6% margin

EPS (Diluted)

$-7.33

Cash Flow

Operating Cash Flow

-$76M

Free Cash Flow

-$77M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$78M

Total Liabilities

$23M

Stockholders' Equity

$55M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$29M	-29.5%
Gross Profit	-$43M	-$34M	-26.9%
Operating Income	-$70M	-$52M	-34.8%
Net Income	-$69M	-$51M	-34.5%